54.80CHF-0.54%Mkt Cap: 3.47B $P/E: 2.24Today
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medica…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.47B $
Enterprise Value-42.83M $
Revenue (TTM)1.21B $
Gross Profit1.21B $
Net Income (TTM)659.83M $
Revenue/Share21.96 USD
Last Price54.80 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountryCH
SectorFinancial Services
IndustryBiotechnology
ISINCH0038389992
Valuation
P/E (Trailing)2.24
P/E (Forward)-83.77
PEG—
EV/EBITDA—
EV/Revenue-0.04
P/S2.87
P/B0.99
EPS (TTM)24.57
EPS (Forward)-0.66
52W Range
54.2035% of range55.90
52W High55.90 CHF
52W Low54.20 CHF
Profitability
Gross Margin100.00%
Oper. Margin97.74%
EBITDA Margin0.00%
Profit Margin98.49%
ROE20.81%
ROA20.75%
Growth
Revenue Growth116257.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF345.57M $
CapEx (TTM)—
FCF Margin233.15%
FCF Yield81.30%
Net Debt-3.51B $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio583.97
Quick Ratio583.91
Book Value/Sh55.93 CHF
Cash/Share55.78 CHF
Dividends
Fwd Div Rate2.250 CHF
Trail. Div Rate2.250 CHF
Div. Yield4.05%
5Y Avg Yield5.67%
Payout Ratio9.16%
Ex-Div DateMar 23, 2026
Pay DateMar 25, 2025
Splits
Last Split5:1
Split DateMar 29, 2016
Analyst Consensus
Rating—
Target (Mean)69.00 CHF
Upside (mean)+25.9%
Target Range65.00 CHF – 73.00 CHF
CHF65.00+25.9% to meanCHF73.00
# Analysts2
Ownership
Shares Out.55.15M
Float—
Insiders0.08%
Institutions19.25%
Technical
SMA 5049.78 (+10.1%)
SMA 20046.38 (+18.2%)
Beta0.66
S&P 52W Chg18.16%
Avg Vol (30d)80.30K
Avg Vol (10d)86.96K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—